Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Chronic Granulomatous Disease with Severe Infection
NCT03080480Phase 2Terminated
- Sponsor
- Children's Hospital of Fudan University
- Start
- Sep 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in chronic granulomatous disease (CGD), sponsored by Children's Hospital of Fudan University. Started Sep 2017; status: terminated.
02
Drugs
pioglitazone
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on NCT03080480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080480.